Close Menu

NEW YORK (GenomeWeb) – MDxHealth announced today that it has been awarded a US General Services Administration contract to supply its ConfirmMDx prostate cancer test to the Department of Veterans Affairs.

According to the company, the five-year contract provides coverage of ConfirmMDx testing at the Medicare rate for veterans with the VA health system beginning February 1. Additional terms were not disclosed.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Jul
23
Sponsored by
Qiagen

This webinar will discuss how the Molecular Pathology Laboratory at the University of Oklahoma (OUMP) is using a new quality improvement model to support molecular testing of oncology patients. 

Jul
30
Sponsored by
Mission Bio

This webinar will outline a project that performs large-scale and integrative single-cell genome and transcriptome profiling of pediatric acute lymphoblastic leukemia (ALL) cases at diagnosis, during drug treatment, and in case of relapse.